Dorian Gray Syndrome of Upfront Immunotherapy in Patients With Non-Small-Cell Lung Cancer and High PD-L1 Expression

Lizza E L Hendriks, Jordi Remon, Benjamin Besse*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)e87-e89
Number of pages3
JournalClinical Lung Cancer
Issue number2
Early online date12 Jun 2021
Publication statusPublished - Mar 2022


  • Immune checkpoint inhibition
  • Programmed death-ligand 1
  • non-small cell lung cancer
  • phase III clinical trials
  • real-world data

Cite this